[
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007658"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "whole cell cancer vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007658",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that uses whole cells to deliver cancer antigen(s)."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/VO_0000177",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/VO_0000177",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001"
    ],
    "hasDirectChildren": true,
    "numDescendants": 55,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 55,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007659"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "whole tumor cell cancer vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007659",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A whole cell cancer vaccine that uses whole tumor cells to deliver cancer antigen(s)."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/VO_0007658",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/VO_0007658",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007658",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007658",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007660"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "DNA cancer vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007660",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that is composed of a plasmid vaccine vector (a circular double stranded DNA molecule) containing the whole of parts of genes encoding one or more vaccine antigen proteins."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0000177"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0000177"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503"
    ],
    "hasDirectChildren": true,
    "numDescendants": 94,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 94,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007661"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "GD2-CAR vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007661",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made with T cells  genetically engineered to express anti-GD2 Chimeric Antigen Receptor to treat patients with children and young adults with GD2+ solid tumors, including neuroblastoma. The T cells may have an antitumor effect. They can be used in combination with AP1903 and Cyclophosphamide. (NCT02107963) There are increased CXCR3- classical monocytes in patients as CAR-T numbers waned."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/VO_0007657",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/VO_0007657",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007662"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid KLH conjugate vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007662",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine used to treat patients with small cell lung cancer by using several components (small cell lung cancer targets) that have been tested individually in patients with small cell lung cancer or other cancers (GD2, GD3, Globo H, Fucosyl GM1 and N-propionylated polysialic acid) so that the body will make antibodies to the vaccine which will also react against the cancer. Two other substances (KLH and OPT-821) are added which boost the immune system. Vaccination with the pentavalent KLH conjugate vaccine may induce production of IgG and IgM antibodies as well as an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumors expressing any of these antigens."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: GD 2|Gene name: GD3|Gene name: Globo H|Gene name: fucosyl GM1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000195",
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000195",
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000195",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000195",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007663"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "genetically engineered allogeneic prostate carinoma cells secreting interleukin-2 and interferon gamma"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007663",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine made with HLA class I-matched allogeneic human prostate carcinoma cells that are genetically engineered to secrete interleukin-2 and interferon gamma for patients with prostate carcinoma. Interleukin-2 may stimulate a person's white blood cells including natural killer cells to kill prostate cancer cells. Interferon gamma may interfere with the growth of the cancer cells. Combining interferon gamma with interleukin-2 may be a more effective treatment for prostate cancer."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: IL2|Gene name: Interferon gamma"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007664"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "GM-K562 cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007664",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine comprised of K562 cells transfected with the granulocyte macrophage-colony stimulating factor (GM-CSF) gene with potential immunopotentiating properties. This vaccine may stimulate the host immune system to produce an antitumoral T-lymphocyte response, thereby inhibiting tumor growth. A cultured cell line is genetically changed to secrete GM-CSF mixed with irradiated leukemia cells obtained from a patient. Vaccines made from gene-modified cancer cells may help the body build an effective immune response to kill cancer cells. Imatinib mesylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving vaccine therapy together with imatinib mesylate may be an effective treatment for chronic myelogenous leukemia. The vaccine can also be combined with stem cell transplantation. The vaccine may induce an immune response to common myeloid antigens (e.g., Wilms' tumor-1 [WT-1], survivin, or proteinase-3) in patients with Myelodysplastic Syndrome. "
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: GM-CSF"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007665"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "GM.CD40L cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007665",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine composed of irradiated tumor cells transduced with granulocyte-macrophage colony-stimulating factor (GM-CSF) and CD40-ligand (CD40L) genes. The vaccine may stimulate an anti-tumoral dendritic cell-mediated host immune response. Universal GM-CSF-producing and CD40L-expressing bystander cell line is used to form an autologous tumor cell-based vaccine for patients with mantle cell lymphoma in order to make the body build an effective immune response to kill cancer cells. It can be used in combination with Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Dexamethasone, and IL-2. The vaccine can be done with bystander and autologous tumor cells for patients with malignant melanoma. It can also be combined with lenalidomide for patients with myelodysplastic syndrome (MDS)."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: CD40LG"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007666"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "gp100 mature dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007666",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine using dendritic cells (a kind of white blood cell) as a vaccine could stimulate your own immune system to react to your melanoma cells. Autologous dendritic cells are pulsed with 2 gp100 melanoma peptides (G209-2M and G280-9V) plus up to an additional 10 unique melanoma tumor-specific peptides. Patients also receive cyclophosphamide 300mg/m2 IV in order to deplete regulatory T cells."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: gp100"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007667"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "GVAX leukemia vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007667",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine that uses irradiated, adenovirus transduced autologous myeloblasts to secrete granulocyte-macrophage colony-stimulating factor (GVAX) early after allogeneic hematopoietic stem cell transplantation (HSCT) to induce potent immune responses. The vaccine may prevent advanced myelodysplastic syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), or acute myeloid leukemia (AML) from relapsing after stem cell transplant. The patients own cancer cells are engineered to produce a protein called GM-CSF, which can be effective in stimulating a powerful immune response specific to that cancer. "
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: GM-CSF"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007668"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "H3.3K27M-specific peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007668",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine composed of a peptide derived from histone H3.3 containing the amino acid substitution mutation lysine (Lys) 27-to-methionine (H3.3K27M), with potential immunoactivating and antineoplastic activities. Following the administration of the vaccine, the immune system may exert a cytotoxic T-lymphocyte (CTL)-mediated immune response against H3.3K27M-expressing tumor cells. A lysine 27-to-methionine (K27M) somatic mutation at histone H3 variant (H3.3) is a feature mutation in diffuse intrinsic pontine gliomas (DIPGs). This vaccine contains an H3.3-K27M targeted neoantigen peptide that can be taken up by antigen-presenting cells (APCs). APCs can present the peptide with the major histocompatibility complex (MHC) molecules on cell surface, thereby activating neoantigen-specific T cells and triggering corresponding cytotoxic T cell immune responses to eliminate H3.3-K27M-expressing DIPG cells."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007669"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "HER-2-neu, CEA peptides, GM-CSF, montanide ISA-51 vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007669",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine comprised of HER-2-neu and carcinoembryonic antigen synthetic (CEA) peptides, combined with the adjuvants granulocyte-macrophage colony stimulating factor (GM-CSF), and Montanide ISA-51 with potential antineoplastic activity. The vaccine may stimulate a cytotoxic T-cell response against HER-2-neu- and CEA-expressing tumor cells. Vaccines made from peptides may make the body build an immune response to kill tumor cells. This vaccine is compromised of HER-2-neu and carcinoembryonic antigen synthetic peptides, sargramostim (GM-CSF), and Montanide ISA-51, and aims to cause an immune response in patients with stage IIB, III, or IV colorectal cancer."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: carcinoembryonic antigen|Gene name: HER-2-neu"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005426",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005426",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005426",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005426",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007670"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "HER2 ICD peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007670",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine made from peptides that may help the body build an effective immune response to kill tumor cells. Patients with HER2 positive locally advanced breast cancer can be vaccinated with a HER2 Intracellular Domain (ICD) peptide-based vaccine administered concurrently with trastuzumab. The vaccine may lead to an immune response (HER2 specific T cell immunity and/or the development of intramolecular epitope spreading)."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: HER-2/neu"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007671"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "HLA neoantigen vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007671",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine for vaccination with neoantigens that can both expand pre-existing neoantigen-specific T-cell populations and induce a broader repertoire of new T-cell specificities in cancer patients, tipping the intra-tumoural balance in favour of enhanced tumour control. The vaccine targets up to 20 predicted personal tumour neoantigens. The vaccine induced CD4+ and CD8+ T cells responses. These T cells discriminated mutated from wild-type antigens, and in some cases directly recognized autologous tumour."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: HLA"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007672"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "HLA-A1, HLA-A2, and CD40-ligand pulsed dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007672",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine made from a person's white blood cells mixed with tumor proteins (HLA-A1- and HLA-A2.1-restricted peptides derived from melanoma-associated tumor antigens) and CD40-ligand, and may make the body build an immune response to kill tumor cells. This is combined with denileukin diftitox, which "
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: HLA-A|Gene name: CD40L"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007673"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "hodgkin's antigens-GM-CSF-expressing cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007673",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of Hodgkin lymphoma cells transfected with the granulocyte macrophage-colony-stimulating factor (GM-CSF) gene with potential antineoplastic activity. Hodgkin antigens-GM-CSF-expressing cell vaccine may stimulate a cytotoxic T-lymphocyte (CTL) immune response against Hodgkin lymphoma-associated antigens, which may result in the lysis of tumor cells expressing these antigens. Also, transfected Hodgkin lymphoma cells secrete GM-CSF, which may potentiate the CTL response against Hodgkin lymphoma-associated antigens. Vaccines made from a tumor antigen may help the body build an effective immune response to kill tumor cells. This vaccine contains cells expressing Hodgkin's antigens and GM-CSF, and could cause an immunological response in Hodgkin's lymphoma patients."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007674"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "HPV E6/E7-encoding semliki forest virus vaccine Vvax001"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007674",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine consisting of a recombinant, attenuated, replication-incompetent form of the Semliki Forest Virus (SFV) vector encoding the viral oncoproteins E6 and E7 derived from the human papillomavirus (HPV), with potential immunomodulating and antineoplastic activities. The vaccine induces expression of the E6/E7 proteins and stimulates both the innate and the adaptive immune system, resulting in a potent cytotoxic T-lymphocyte (CTL) response against and lysis of tumor cells expressing HPV E6 and E7. The vaccine may help to treat patients with a history of (pre) malignant cervical lesions."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: E6|Gene name: E7"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007675"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "hyperacute - breast cancer vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007675",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine composed of irradiated allogeneic breast cancer cell lines (HAB-1 and HAB-2) that have been transduced with a recombinant Moloney murine leukemia virus (MoMLV)-based retroviral vector expressing the murine alpha (1,3) GT gene. The immune response to the foreign substance could stimulate the immune system to attack the patient's own cancer cells that have similar proteins without this sugar pattern, causing the tumor to remain stable or shrink."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: Ggta1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007676"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "hyperacute-melanoma vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007676",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine composed of irradiated allogeneic melanoma cell lines (HAM-1, HAM-2 and HAM-3). These cell lines have been transduced with a recombinant Moloney murine leukemia virus (MoMLV)-based retroviral vector expressing the murine alpha(1,3)GT gene, a mouse gene that causes the production of a foreign pattern of protein-sugars on the cell surface. The immune response to the foreign substance could stimulate the immune system to attack the patient's own cancer cells that have similar proteins without this sugar pattern, causing the tumor to remain stable or shrink."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: Ggta1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007677"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "hyperacute-prostate cancer vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007677",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine composed of irradiated allogeneic prostate cancer cell lines (HAP-1 and HAP-2) that have been transduced with a recombinant Moloney murine leukemia virus (MoMLV)-based retroviral vector expressing the murine alpha (1,3) GT gene, a mouse gene that causes the production of a foreign pattern of protein-sugars on the cell surface. It is hoped that the immune response to the foreign substance will stimulate the immune system to attack the patient's own cancer cells that have similar proteins without this sugar pattern, causing the tumor to remain stable or shrink.. The expression of the murine alpha (1,3) galactosyltransferase [alpha (1,3) GT] gene results in the cell surface expression of alpha (1,3) galactosyl-epitopes (alpha-gal) on membrane glycoproteins and glycolipids."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: Ggta1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007678"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "IDO peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007678",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine derived from the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO) with potential immunomodulating and antineoplastic activities. It may activate the immune system to induce an immune response against IDO-expressing tumor cells, which may restore the proliferation and activation of various immune cells including cytotoxic T-lymphocytes (CTLs), natural killer cells (NKs), and dendritic cells (DCs), and may eradicate IDO-expressing tumor cells through a CTL-mediated response. This vaccine, using a small fragment of IDO, can be used in combination with either Ipilimumab or Vemurafenib to treat malignant melanoma that has metastasized. "
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: IDO"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007679"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "IL-2 peptide and GM-CSF-in-adjuvant melanoma vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007679",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine compromised of melanoma peptides plus GM-CSF-in-adjuvant. It is combined with low-dose IL-2 therapy, which could significantly enhance the immunologic efficacy."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007680"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "IL15-DC vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007680",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine made with autologous dendritic cells that are manufactured with GM-CSF, IL15 and loaded with melanoma/HIV peptides and KLH; then activated with LPS and CD40 Ligand.IL15 is a T cell growth factor that could have a very important role in cancer immunotherapy. IL15 DCs are particularly efficient at priming functional melanoma specific CD8+ T cells. The use of IL15 in the manufacture of the DC vaccine could result in an improved immunotherapy product for melanoma patients."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: IL15"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007681"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "intracel KLH vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007681",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that could teach T-cells to detect and kill cancer cells better. Intracel KLH is given without adjuvant subcutaneously and with Tetanus Toxoid 0.5 ml intramuscularly."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0000577"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0000577"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007682"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "KLH and tumor lysate pulsed DC vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007682",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made with dendritic cells pulsed with KLH and tumor lysate for patients with neuroblastoma."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007683"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "KLH-id vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007683",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made of tumor protein taken from a cancer patient's plasma (liquid part of the blood) and KLH (a protein designed to increase the immune response of the vaccine)."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007684"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "KLH-pulsed autologous dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007684",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made with autologous dendritic cells  pulsed with KLH for this vaccination, combined with radiation or a gene therapy agent, TNFerade. TNFerade or radiation serves to generate cell death stimulating the immune response. The dendritic cell vaccine may direct a distant and lasting effective anti-tumor immune response to achieve a local and systemic clinical benefit."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007685"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "KRAS-targeted mRNA vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007685",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine used alone or in combination with PD-1 inhibitor in patients with advanced solid tumors with KRAS mutation (G12C, G12D, or G12V) and HLA type HLA-A11:01 or HLA C08:02. The vaccine is a lipid nanoparticle (LNP)-formulated mRNA-based cancer vaccine that targets the most commonly occurring KRAS mutations (G12D, G12V, and G12C). The mRNA-derived KRAS-targeted vaccine V941 (mRNA-5671) is taken up and translated by antigen presenting cells (APCs). Following translation, the epitopes are presented via major histocompatibility complex (MHC) molecules on the surface of the APCs. This leads to an induction of both cytotoxic T-lymphocyte (CTL)- and memory T-cell-dependent immune responses that specifically target and destroy tumor cells harboring these specific KRAS mutations."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: KRAS"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007686"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "LMP2A-loaded conventional DC vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007686",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine made with Epstein Barr Virus (EBV)-derived tumor antigen, Latent Membrane Protein-2 (LMP2)-loaded dendritic cell (DC) vaccines are administered alone or co-administered with the TLR9 ligand, DUK-CPG-001, in patients with EBV+ lymphoma in the setting of autologous stem cell transplant with infusion of mature T cells. It may induce EBV derived tumor antigen specific CD8+ T cell response in patients with EBV+ lymphoma in the setting of autologous stem cell transplant."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: EBV|Gene name: LMP2"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007687"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007687",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine comprised of multiple peptides derived from MAGE-1A, Her-2/neu, and folate binding protein (FBP), with potential immunostimulating and antineoplastic properties. The MAGE-A1, Her-2/neu, FBP peptides cancer vaccine includes the peptides MAGE-A1:161-169, FBP:191-199, Her-2/neu:369-377, MAGE-A1:96-104, and Her-2/neu:754-762. Vaccination with this cancer vaccine may activate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing the corresponding antigens, resulting in tumor cell lysis. The vaccine compromises synthetic ovarian cancer-associated peptides administered with a synthetic tetanus toxoid helper peptide emulsified in Montanide ISA-51 before or after paclitaxel and carboplatin in patients with stage III-IV ovarian epithelial, primary peritoneal cavity, or fallopian tube cancer undergoing optimal cytoreductive surgery. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving vaccine therapy and chemotherapy after surgery may kill any tumor cells that remain after surgery."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: MAGE-A1|Gene name: HER2-neu|Gene name: FBP"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005493",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005493",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005493",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005493",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007688"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MART-1, tyrosinase and MAGE-A6 autologous DC vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007688",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine made with autologous dendritic cells (DC) are transduced with the MART-1, tyrosinase and MAGE-A6 (melanoma associated antigens, MAA) genes for melanoma patients. Some patients also receive interferon-alfa 2b (IFN) intravenously."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: MART-1|Gene name: tyrosinase|Gene name: MAGE-A6"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007689"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "mature dendritic cell melanoma vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007689",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that may elicit a cytotoxic T-cell (CTL) response against cancer cells. Autologous dendritic cells are pulsed with melanoma tumor-specific peptides. The mature dendritic cell (mDC3/8) vaccine (primer and booster) in patients with stage III and stage IV melanoma is followed by treatment with pembrolizumab (anti-PD-1 therapy). Using dendritic cells (a kind of white blood cell) as a vaccine could stimulate your own immune system to react to your melanoma cells."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007690"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MDX-1379 (gp100) melanoma peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007690",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine made up of two peptides that are pieces of a bigger melanoma protein (gp100). These peptides bind to HLA-A2 which is then recognized by T cells. It could be given in combination with MDX-010 (ipilimumab, BMS-734016). MDX-010 (anti-CTLA4) antibodies are designed to keep the immune system running by blocking CTLA-4 from down-regulating T cell activation."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: gp100"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007691"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MDX-CTLA4 antibody/tyrosinase/gp100/MART-1 melanoma vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007691",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine composed of CTLA-4 antibody; tyrosinase, gp100, and MART-1 peptides; and incomplete Freund's adjuvant (IFA) with or without interleukin-12 in patients with resected stage III or IV melanoma."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: tyrosinase|Gene name: gp100|Gene name: MART-1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007692"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "melanoma helper peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007692",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of peptides derived from melanoma-associated antigens and an adjuvant peptide derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic T-cell response against tumor cells expressing melanoma-associated antigens, resulting in tumor cell lysis. Vaccines made from peptides may make the body build an immune response to kill tumor cells. Vaccines using melanoma peptides from cytotoxic T cells and helper T cells could work in treating patients with metastatic melanoma. This vaccine contains 12 melanoma peptides restricted by Human Leukocyte Antigen (HLA)-A1, -A2, or -A3 and 6 melanoma helper peptides restricted by HLA-DR molecules emulsified with sargramostim (Granulocyte-macrophage colony-stimulating factor, GM-CSF) and Montanide ISA-51 or Montanide ISA-51 VG (ISA-51)."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007693"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "mixed bacterial cancer vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007693",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine containing a mixture of killed bacteria with potential immunostimulatory and antineoplastic activities. Mixed bacteria vaccine (MBV or Coley's toxins) consists of a pyrogenic bacterial lysate derived from Serratia marcescens and Streptococcus pyogenes; the active components in the lysate may be lipopolysaccharide (LPS), a component of the Gram-negative bacterial cell wall of Serratia, and streptokinase, an enzyme produced by Streptococcus pyogenes. LPS has been shown to stimulate the host humoral immune response and induce the release of various antitumor cytokines such as tumor necrosis factor (TNF) and interleukin-12 (IL-12). The mixed bacteria vaccine (MBV) is administered at a starting dose of 250 EU (1 µL) and escalated in each patient to a dose inducing the desired pyrogenic effect, defined as a body temperature of 38°C to 39.5°C. It is given to patients with malignant tumors that expressed the NY-ESO-1 antigen. It is designed to induce immunological effects and tumor response following vaccination. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000315",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000315",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000315",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000315",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007694"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "mRNA neoantigen tumor vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007694",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine with or without PD-1/L1 may help treat patients with advanced gastric cancer. A personalized mRNA tumor vaccine encoding neoantigen may also help treat patients with advanced esophageal squamous carcinoma, gastric adenocarcinoma, pancreatic adenocarcinoma and colorectal adenocarcinoma. The vaccine can also be used in combination with PD-1 for the treatment of advanced solid tumors."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007695"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "mRNA tumor antigen DC vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007695",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made with dendritic cells (DCs) pulsed with mRNA encoded tumor antigens. These personalized cell vaccines may lead to antitumor specific T cell responses. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007696"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "mRNA-based personalized cancer vaccine NCI-4650"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007696",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine targeting up to fifteen tumor-associated antigens (TAAs) that are specifically expressed by a patient's cancer cells, with potential immunostimulatory and antineoplastic activities. Up to fifteen neoantigen epitopes are incorporated in a proprietary formulation designed to maximize mRNA delivery and minimize mRNA-triggered immune responses. The mRNA-based PCV NCI-4650 is taken up and the mRNAs are translated by antigen presenting cells (APCs). Then, the expressed epitopes are presented via major histocompatibility complex (MHC) molecules on the surface of the APCs. This induces both cytotoxic T-lymphocyte (CTL)- and memory T-cell-dependent immune responses that specifically target and destroy the patient's cancer cells that express these neoantigens. Exome sequencing can identify certain gene mutations in a person's tumor. This can then be used to create cancer treatments. This mRNA vaccine might cause certain tumors to shrink. Immunogenic neoantigens and can predict for neoantigens binding the patient human leukocyte antigen (HLA) molecules from melanoma or epithelial cancer patients and use these epitopes for a personalized therapeutic messenger ribonucleic acid (mRNA) vaccine."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000186",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007697"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MT-201-GBM monocyte vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007697",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of autologous monocytes loaded with mRNA encoding the human cytomegalovirus (CMV) matrix protein pp65 (65 kDa lower matrix phosphoprotein; UL83) as a fusion protein with the lysosome-associated membrane protein (LAMP), with potential immunostimulatory and antineoplastic activities. The autologous CMV-pp65-LAMP mRNA loaded monocyte vaccine MT-201-GBM exposes the immune system to the CMV pp65 peptide, which may elicit a cytotoxic T-lymphocyte (CTL) response against CMV pp65-expressing tumor cells. The incorporation of LAMP may route CMV pp-65 antigens into the lysosomal compartment, resulting in enhanced MHC class II antigen presentation, thereby promoting CD4-positive T-cell responses. MT-201-GBM (pp65CMV antigen monocytes) are administered to patients newly diagnosed with a type of brain tumor called glioblastoma (GBM) that has an unmethylated MGMT (O[6]-methylguanine-DNA methyltransferase) (MGMT) gene promoter. The vaccine is made from a type of immune cell called monocytes, which have been engineered to express a cytomegalovirus (CMV) protein. Patients also receive standard radiation therapy combined with temozolomide."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007698"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MUC1 peptide-poly-ICLC vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007698",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine containing mucus 1 (MUC1) peptide and the adjuvant poly-ICLC with potential immunostimulatory and antineoplastic activities. MUC1 peptide-poly-ICLC adjuvant vaccine may induce the host immune system to mount a cytotoxic T cell response against MUC1-expressing tumor cells. MUC1 peptide-poly-ICLC adjuvant vaccine in boosting systemic immunity to MUC1 in women with stage I-III 'triple-negative' [i.e., ER(-) PR(-) HER2/neu(-)] breast cancer. MUC1 peptide-Poly-ICLC vaccine could also work in preventing lung cancer in current and former smokers at high risk for lung cancer. Vaccines made from peptides may help the body build an effective immune response to kill cells. MUC1 peptide-Poly-ICLC vaccine may stimulate the body's immune system and slow or stop the changes from normal to pre-cancer to cancer."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: MUC-1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007699"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "multi-epitope HER2 peptide vaccine TPIV100"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007699",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine comprised of four peptides derived from the tumor-associated antigen (TAA) HER-2/neu (ErbB-2), with potential immunomodulating and antineoplastic activities. The four peptides may induce a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing the HER-2/neu antigen, which may result in the inhibition of proliferation in Her-2/neu-expressing tumor cells. TPIV100 is a type of vaccine made from HER2 peptide that may help the body build an effective immune response to kill tumor cells that express HER2. Sargramostim increases the number of white blood cells in the body following chemotherapy for certain types of cancer and is used to alert the immune system. TPIV100 and sargramostim could work in treating patients with HER2 positive, stage II-III breast cancer."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: HER2"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007700"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "multi-epitope melanoma peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007700",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine consisting of a combination of peptides derived form several melanoma epitopes. Vaccination with multi-epitope melanoma peptide vaccine stimulates the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing the corresponding antigens, resulting in tumor cell lysis. This vaccine may stimulate a broader CTL response compared to single-antigen vaccines. Vaccines made from melanoma peptides or antigens may help the body build an effective immune response to kill tumor cells in patients with stage IIC-IV melanoma. This vaccine is a tyrosinase/gp100/MAGE-3 class I peptide vaccine combined with Montanide ISA 51 or ISA 51 VG with CpG adjuvant 7909 in human leukocyte antigen (HLA) class I A1, A3 or A11 and B44 matched patients with surgically resected stages IIC, III and IV melanoma."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: tyrosinase|Gene name: gp100|Gene name: MAGE-A3|Gene name: HLA-A|Gene name: HLA-B"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007701"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "multiantigen liposome loaded dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007701",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine for which Advanced Renal Cell Carcinoma patients undergo total nephrectomy to harvest primary tumor for vaccine preparation. Dendritic cells are then pulsed with multiantigens or tumor cells. Some patients also receive vaccination with irradiated autologous tumor lysate. The vaccine may make the body build an immune response to kill tumor cells."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005494",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005494",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005494",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005494",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007702"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "multipeptide XS15 vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007702",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine adjuvant and synthetic Toll-like receptor (TLR) type 1 and 2 ligand composed of a lipopeptide containing a water-soluble derivative of Pam3-Cys, the biologically active component of the mycobacterial 19 kDa lipoprotein of mycobacteria, that is covalently linked to a synthetic peptide (GDPKHPKSF), with potential immunostimulating activity. TLR1/2 agonist Pam3Cys-GDPKHPKSF targets, binds to and activates TLR1/2, which induces CD8- and T-helper 1 CD4-positive T-cell responses. This may enhance T-cell-mediated immune responses when administered together with peptide vaccine. A multi-peptide vaccine can be used in combination with the TLR1/2 ligand XS15 in CLL patients undergoing ibrutinib-based regimes. Applying several CLL-associated antigens simultaneously increases the likelihood that a multi-clonal, broad and at the same time highly specific T-cell response is mounted, thereby preventing potential tumor escape mechanisms. The novel TLR1/2 ligand (XS15, developed in Tübingen) that (i) is water-soluble and (ii) GMP-amenable, (iii) non-toxic and (iv) effective in inducing T cells specific for peptides in vivo. A personalized multi-peptide vaccination can also be used in combination with the TLR1/2 ligand XS15 for individual patients with advanced solid and hematological malignancies without any approved treatment options. "
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: TLR1|Gene name: TLR2"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007703"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "multiple signals loaded dendritic cells vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007703",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that can efficiently present T cells with antigens of HCC sensitize their antitumor properties meanwhile low dose cyclophosphamide (CY) can effectively improve the microenvironment of immunity. Multiple signals loaded dendritic cells vaccine combined low dose of cyclophosphamide combining with radical surgery or TACE or targeted agents for patients with hepatocellular carcinoma coul prolong their survival time."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005499",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005499",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005499",
      "http://purl.obolibrary.org/obo/VO_0005429",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005499",
      "http://purl.obolibrary.org/obo/VO_0005429",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007704"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "mutated neopeptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007704",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine with neopeptides designed with single amino acid mutations to enhance their immunogenicity and bind to HLA class I and II molecules. Exome and RNA sequencing as well as in silico HLA-binding predictions to autologous HLA molecules were used to identify candidate neopeptides. Subsequently, in silico HLA-anchor placements were used to deduce putative T-cell receptor (TCR) contacts of peptides. Single amino acids of TCR contacting residues were then mutated by amino acid replacements. TIL-derived CD4+ T-cell clones showed strong responses and tumor cell lysis not only against the designed neopeptide but also against the unmutated natural peptides of the tumor. Turning tumor self-peptides into foreign antigens by introduction of designed mutations is a promising strategy to induce strong intratumoral CD4+ T-cell responses in a cold tumor like glioblastoma."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: HLA"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007705"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MVA-BN-CV301 vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007705",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine consisting of a proprietary version of the recombinant vaccinia viral vector, modified vaccinia Ankara-Bavarian Nordic (MVA-BN), encoding both the two human tumor-associated antigens (TAAs) carcinoembryonic antigen (CEA) and mucin-1 (MUC-1), and TRICOM, which is comprised of the three human immune-enhancing co-stimulatory molecules B7-1, ICAM-1 and LFA-3, with potential immunostimulatory and antineoplastic activities. MVA-BN-CV301, followed by multiple boosting doses of the fowlpox virus (FPV) vaccine CV301 may lead to a cytotoxic T-lymphocyte (CTL) response against CEA- and MUC-1-expressing tumor cells is activated. In addition, the CV301-dependent anti-tumor CTL response upregulates the expression of programmed cell death ligand 1 (PD-L1); therefore, when CV301 is combined with a programmed cell death 1 (PD-1) immune checkpoint inhibitor, the antitumor effect may be increased. CV301 is a poxviral-based vaccine comprised of recombinant Modified vaccinia Ankara (MVA-BN-CV301, prime) and recombinant fowlpox (FPV-CV301, boost). CV301 contains transgenes encoding two (2) tumor-associated antigens (TAA), mucin 1 (MUC1) and carcinoembryonic antigen (CEA), as well as three costimulatory molecules (B7.1, intercellular adhesion molecule 1 (ICAM-1) and lymphocyte function-associated antigen 3 (LFA-3), designated TRICOM). It is given in combination with SX-682 and M7824 for patients with Triple Negative Breast Cancer (TNBC) and Human papilloma virus (HPV) negative head and neck squamous cell carcinoma (HNSCC)."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: MUC1|Gene name: CEA|Gene name: B7.1|Gene name: ICAM-1|Gene name: LFA-3"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007706"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "MVF-HER-2(628-647)-CRL 1005 vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007706",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine of a chimeric peptide immunogen of human epidermal growth factor-2 (HER-2) with antineoplastic property. MVF-HER-2(628-647)-CRL 1005 vaccine, coated with poloxamer CRL-1005 to form microparticles, consists of a mutated HER-2 B-cell epitope, HER-2(628-647), and a promiscuous T cell epitope (amino acid sequence 288-302) of the measles virus fusion protein (MVF). The vaccine may stimulate the host immune response to mount a cytotoxic T-lymphocyte response against tumor cells that overexpress the HER2 protein, resulting in tumor cell lysis. MVF-HER-2(628-647)-CRL 1005 vaccine may induce anti-HER-2 antibody in patients with metastatic or recurrent cancer (Breast, Ovarian, Non-small cell lung cancer, Gastric adenocarcinoma)."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: HER2"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/VO_0007657",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/VO_0007657",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007707"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "NEO-PV-01 vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007707",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of patient-specific mutated peptide epitopes, which are immunogenic and unique to the patient's tumor, with potential immunomodulating and antineoplastic activities. The neoantigen-based anti-cancer vaccine NEO-PV-01 stimulates the host immune system to mount a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis. Both metastatic squamous non-small cell lung cancer (NSCLC) and extensive stage small cell lung cancer (SCLC) are incurable with current therapies, but due to mutations induced by cigarette smoke, typically express a large number of altered proteins that can be recognized as foreign by the immune system. Targeting the immune system against tumor specific antigens using a peptide vaccine could lead to improved response rate and prolonged overall survival with no additional toxicity when combined with Pembrolizumab (monoclonal antibodies that block PD-1/PD-L1 interactions) and standard of care chemotherapy."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  }
]